Do Restrictions on Antipsychotic Use Differ Between Medicare Part D Stand-Alone Versus Medicare Advantage Plans?
J Chou, NJ Brandt, FE Loh… - The Consultant Pharmacist …, 2017 - ingentaconnect.com
OBJECTIVE: The objective of this study was to describe the type of restrictions and
differences among antipsychotic users enrolled in Medicare Part D Stand-Alone (PDPs) and …
differences among antipsychotic users enrolled in Medicare Part D Stand-Alone (PDPs) and …
[PDF][PDF] MINI-SENTINEL REGULATORY ASSESSMENT REPORT OF THE IMPACT OF THE 2010 FDA REGULATORY ACTIONS ON LABA MEDICATION USE
P Wu, DT MD - 2014 - sentinelinitiative.org
Long acting beta2 agonists (LABAs) are sympathomimetic agents that relax airway smooth
muscle. 1-3 They differ from short-acting beta2 agonists (SABAs) and their duration of action …
muscle. 1-3 They differ from short-acting beta2 agonists (SABAs) and their duration of action …